PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4:持股变动声明-董事 Rolfe Lindsey
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4:持股变动声明-董事 Rapaport Robyn
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4:持股变动声明-董事 LAPORTE KATHLEEN
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4:持股变动声明-董事 Ehrlich Christopher B
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4:持股变动声明-高管 Corey Daniel
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4:持股变动声明-高管 Carter Charles Ross
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4:持股变动声明-董事 Byrnes Michael
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4:持股变动声明-高管 ATWOOD BRIAN G
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4/A:持股变动声明(修正)-高管 ATWOOD BRIAN G
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 3/A:首次持股声明(修正)-高管 Corey Daniel
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | D:发行公告
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | SC 13G/A:超过5%持股股东披露文件(修正)-Shaolin Capital Management LLC(0.0%)
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4/A:持股变动声明(修正)-董事 LAPORTE KATHLEEN
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4/A:持股变动声明(修正)-高管 ATWOOD BRIAN G
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | SC 13D/A:超过5%持股股东披露文件(修正)-Jurgen van de Vyver(6.8%),Phoenix Biotech Sponsor, LLC(6.7%)等
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4:持股变动声明-董事 Loewy Caroline M
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4:持股变动声明-董事 Kosacz Barbara
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4:持股变动声明-高管 Geffken Daniel E.
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4:持股变动声明-高管 Fisher Douglas Carl
PHOENIX BIOTECH ACQUISITION CORP C/WTS 01/09/2026 (TO PUR COM) | 4:持股变动声明-董事 LAPORTE KATHLEEN
暂无数据